🇦🇪 Chrft5 in United Arab Emirates

Chrft5 (BASILIXIMAB) regulatory status in United Arab Emirates.

Marketing authorisation

MOH

  • Status: likely_approved

Chrft5 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United Arab Emirates

Frequently asked questions

Is Chrft5 approved in United Arab Emirates?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Chrft5 in United Arab Emirates?

Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.